TSC1
结节性硬化
TSC2
变性高效液相色谱法
外显子
突变
遗传学
生物
基因
多路复用
突变试验
医学
病理
PI3K/AKT/mTOR通路
细胞凋亡
作者
Mi‐Ae Jang,Seung Bong Hong,Jee Hun Lee,Mun Hyang Lee,Man Pyo Chung,Hyung-Jin Shin,Jong‐Won Kim,Chang‐Seok Ki
标识
DOI:10.1016/j.pediatrneurol.2012.02.002
摘要
Tuberous sclerosis complex is a genetic disorder caused by mutations in the genes TSC1 or TSC2. Studies of these mutations are very rare in Korean populations. A previous study identified mutations in only 30% of patients by denaturing high performance liquid chromatography with sequencing. Here, we sought to determine the mutational frequency in Koreans. Eleven patients who fulfilled the diagnostic criteria for tuberous sclerosis complex were included. All patients underwent sequencing of both TSC genes, and if no mutations were evident, multiplex ligation-dependent probe amplification was performed. Mutations were detected by sequencing in 82% (9/11) of patients: 36.4% (4/11) in TSC1 and 45.5% (5/11) in TSC2. Two patients with no mutations carried large deletions that included exon 1 of TSC1 in one patient and exons 1-15 of TSC2 in the other patient. Mutations were completely identified in the present study. Therefore, mutation rates in Korean patients may not be lower than those in other ethnic groups. Direct sequencing followed by multiplex ligation-dependent probe amplification analysis may constitute a rational approach to identify disease-causing mutations in Korean patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI